2-tert-butyl-5-methylbenzo[b]thiophene

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻吩类
• 英文名称: 2-tert-butyl-5-methylbenzo[b]thiophene
• 英文别名: 2-Tert-butyl-5-methyl-1-benzothiophene
• 化学式: C₁₃H₁₆S
• 分子量: 204.336
• InChiKey: HWHLIOUKOIAHHL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 12.0h， 以78%的产率得到2-tert-butyl-5-methylbenzo[b]thiophene
  参考文献：
  名称：

  可见光介导的光催化脱硫方法使（杂）芳烃稠合噻吩的区域特异性烷基加成†

  摘要：

  已经开发了一种光氧化还原介导的（杂）芳烃稠合噻吩的区域特异性烷基加成反应，采用稳定的N-苯甲酰基烷基亚磺酰胺作为烷基源。该协议提供了一种独特的脱硫方法来生成烷基自由基，该自由基通过以氮为中心的自由基中间体进行。

  DOI：

  10.1039/c8cc02052c

文献信息

• 2-ARYL OR HETEROARYL INDOLE DERIVATIVES
  申请人：Chang Ronald K.

  公开号：US20100197657A1

  公开（公告）日：2010-08-05

  The present invention provides 2-aryl or heteroaryl indole derivatives which are ASIC channel modulators, maceutical compositions containing such compounds, and methods of using them as therapeutic agents.

  本发明提供了2-芳基或杂环芳基吲哚衍生物，这些衍生物是ASIC通道调节剂，包含这种化合物的医药组合物，并将其用作治疗剂的方法。
• OXAZOLIDONE COMPOUND, PREPARING METHOD AND APPLICATION THEREOF
  申请人：SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

  公开号：US20150361091A1

  公开（公告）日：2015-12-17

  The present invention relates to the field of a pharmaceutical compound, and more specifically, relates to a new oxazolidone compound, an enantiomer, a diastereoisomer and a raceme thereof, and a mixture thereof, and a pharmaceutically acceptable salt thereof, a preparation method thereof, an application thereof as a bioactive substance in a drug. The compound in the present invention has strong anticoagulant activity, does not affect the activity of thrombin, and can reduce the risk of hemorrhage. A pharmacokinetics experiment shows that the compound in the present invention further has good metabolic characteristics, and has a far better oral bioavailability than a positive contrastive agent rivaroxaban.

  本发明涉及制药化合物领域，更具体地涉及一种新的噁唑烷化合物，其对映异构体、二对映异构体和混合物，以及其药学上可接受的盐、制备方法及其在药物中作为生物活性物质的应用。本发明中的化合物具有强烈的抗凝血活性，不影响凝血酶的活性，并能降低出血风险。药代动力学实验表明，本发明中的化合物还具有良好的代谢特性，并且具有比阳性对照剂利伐沙班更好的口服生物利用度。
• Spirocycle compounds and methods of making and using same
  申请人：H. Lundbeck A/S

  公开号：US11142526B2

  公开（公告）日：2021-10-12

  Provided herein are compounds and compositions useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

  本文提供了可用作 MAGL 调节剂的化合物和组合物。此外，这些化合物和组合物还可用于治疗疼痛。
• Formation of Benzo[<i>b</i>]Thiophenes by Electroreduction of <i>Tert</i>-Alkanecarbodithioates
  作者：Jürgen Voss、Volker Dannat

  DOI：10.1080/10426507.2015.1071370

  日期：2015.12.2

  The electroreduction of a 1:1-mixture of 2-bromobenzyl 2,2-dimethylpropanedithioate and 2-bromo-5-methylbenzyl 2,2-dimethylbutanedithioate led to a mixture of 2-tert-butylbenzo[b]thiophene, 2-tert-amylbenzo[b]thiophene, 2-tert-butyl-5-methylbenzo[b]thiophene and 2-tert-amyl-5-methylbenzo[b]thiophene. The formation of the four different products instead of only the two expected compounds, 2-tert-butylbenzo[b]thiophene and 2-tert-amyl-5-methylbenzo[b]thiophene, which would result from a straightforward reductive cyclization of each dithioester, is indicative of a reaction pathway with cleavage of the intermediates and intermolecular recombination of the fragments.
• SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME
  申请人：LUNDBECK LA JOLLA RESEARCH CENTER, INC.

  公开号：US20200255427A1

  公开（公告）日：2020-08-13

  Provided herein are compounds and compositions useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.